Corporate News     22-Mar-22
Indoco Remedies receives USFDA approval for Lacosamide Tablets
Used as an anticonvulsant drug
Indoco Remedies received final approval from the United States Food & Drug Administration (USFDA) for Lacosamide Tablets USP 50 mg, 100 mg, 150 mg and 200 mg, the generic version of Vimpat® Tablets of UCB, Inc.

Lacosamide Tablets are indicated for the prevention and control of seizures. It is an anticonvulsant/antiepileptic drug.

Previous News
  Indoco Remedies receives Establishment Inspection Report for its unit in Goa
 ( Corporate News - 03-May-23   16:23 )
  Board of Indoco Remedies recommends final dividend
 ( Corporate News - 24-May-23   14:58 )
  Indoco Remedies to declare Quarterly Result
 ( Corporate News - 21-Oct-22   14:02 )
  Indoco Remedies incorporates subsidiary named Warren Remedies
 ( Corporate News - 08-Jun-22   11:29 )
  Indoco Remedies Ltd leads losers in 'B' group
 ( Hot Pursuit - 24-Jan-23   14:45 )
  Indoco Remedies consolidated net profit declines 14.70% in the December 2022 quarter
 ( Results - Announcements 24-Jan-23   12:32 )
  Volumes soar at Indoco Remedies Ltd counter
 ( Hot Pursuit - 31-Aug-21   14:30 )
  Indoco Remedies to conduct board meeting
 ( Corporate News - 11-Jan-23   18:47 )
  Indoco Remedies slumps after dismal Q3 performance
 ( Hot Pursuit - 24-Jan-23   12:37 )
  Volumes jump at United Breweries Ltd counter
 ( Hot Pursuit - 10-Feb-23   14:30 )
  USFDA approves Glycopyrrolate ANDA filed from Indoco's Goa Plant II
 ( Corporate News - 01-Nov-19   12:39 )
Other Stories
  Board of Delhivery approves alteration in capital clause of MoA
  05-Jul-24   19:32
  J B Chemicals & Pharmaceuticals appoints director
  05-Jul-24   19:30
  Infosys announces resignation of senior management personnel
  05-Jul-24   19:22
  JLR Q1 FY25 retail sales up 9% on YoY basis
  05-Jul-24   19:08
  Bajaj Auto launches world's first CNG motorcycle 'Freedom'
  05-Jul-24   18:59
  Agenda for board meeting of Power Grid Corporation of India
  05-Jul-24   18:46
  Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
  05-Jul-24   18:06
  Vipul to hold board meeting
  05-Jul-24   17:15
  Markobenz Ventures to convene board meeting
  05-Jul-24   17:15
  Dhanashree Electronics to declare Quarterly Result
  05-Jul-24   17:15
Back Top